Literature DB >> 647165

Central adrenoceptors and cholinoceptors in cardiovascular control.

K P Bhargava, I P Jain, A K Saxena, J N Sinha, K K Tangri.   

Abstract

1. In cats anaesthetized with chloralose, adrenoceptor and cholinoceptor agonists and antagonists were localized to the posterior hypothalamus (PH), lateral medullary pressor area (LMPA) and spinal autonomic loci to delineate the role of central cholinoceptors and adrenoceptors in cardiovascular control. 2 All along the neuroaxis, the alpha-adrenoceptors seem to subserve an inhibitory and the beta-adrenoceptors a facilitatory role in cardiovascular control. There appear to be a predominance of alpha-adrenoceptors at the medullary level and beta-adrenoceptors at the hypothalamic level. 3 The nicotinic cholinoceptors at the hypothalamic, medullary and spinal levels were facilitatory, whereas muscarinic cholinoceptors were inhibitory for cardiovascular control. However, muscarinic receptors were undetectable at the posterior hypothalamus. 4 The central cardiovascular effects of nicotine are attributed to nicotinic receptor activation and release of central catecholamines. 5 There appears to be a relationship between central cholinergic and adrenergic mechanisms in cardiovascular control.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 647165      PMCID: PMC1668279          DOI: 10.1111/j.1476-5381.1978.tb07768.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

1.  The spinal compression vasomotor response as a pharmacological tool.

Authors:  K P BHARGAVA; J K KULSRESHTHA
Journal:  Arch Int Pharmacodyn Ther       Date:  1959-05-01

2.  Experiments on the fate of histamine and acetylcholine after their injection into the cerebral ventricles.

Authors:  W B BHAWE
Journal:  J Physiol       Date:  1958-02-17       Impact factor: 5.182

3.  Pressor-depressor blood pressure responses in the cat after intraventricular injection of drugs.

Authors:  B S NASHOLD; E MANNARINO; M WUNDERLICH
Journal:  Nature       Date:  1962-03-31       Impact factor: 49.962

4.  Evidence for an alpha-sympathomimetic component in the effects of catapresan on vasomotor centres: antagonism by piperoxane.

Authors:  H Schmitt; S Fenard
Journal:  Eur J Pharmacol       Date:  1971       Impact factor: 4.432

5.  Centrally mediated cardiovascular responses to isoprenaline.

Authors:  D J Gagnon; K I Melville
Journal:  Int J Neuropharmacol       Date:  1967-07

6.  Superfusion of the hypothalamus with gamma-aminobutyric acid. Effect on release of noradrenaline and blood pressure.

Authors:  A Philippu; H Przuntek; W Roensberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

7.  Further evidence relating to the mode of action of nicotine in the central nervous system.

Authors:  A K Armitage; G H Hall
Journal:  Nature       Date:  1967-06-03       Impact factor: 49.962

8.  Cardiovascular responses to injections of cholinomimetic drugs into the cerebral ventricles of unanaesthetized dogs.

Authors:  W J Lang; M L Rush
Journal:  Br J Pharmacol       Date:  1973-02       Impact factor: 8.739

9.  Blood pressure effects obtained by drugs applied to the ventral surface of the brain stem.

Authors:  P G Guertzenstein
Journal:  J Physiol       Date:  1973-03       Impact factor: 5.182

10.  Perfusion of cerebral ventricles: effects of drugs on outflow from the cisterna and the aqueduct.

Authors:  B K BHATTACHARYA; W FELDBERG
Journal:  Br J Pharmacol Chemother       Date:  1958-06
View more
  9 in total

1.  β adrenergic receptor modulation of neurotransmission to cardiac vagal neurons in the nucleus ambiguus.

Authors:  R J Bateman; C R Boychuk; K E Philbin; D Mendelowitz
Journal:  Neuroscience       Date:  2012-02-24       Impact factor: 3.590

2.  Evidence for involvement of alpha 2-adrenoceptors in the nucleus ambiguous in baroreflex-mediated bradycardia.

Authors:  S Gurtu; D K Sharma; J N Sinha; K P Bhargava
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-07       Impact factor: 3.000

3.  Central effects of paraoxon on haemodynamics in the cat.

Authors:  J H de Neef; A J Porsius
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-09       Impact factor: 3.000

4.  An analysis of the alpha-adrenoceptor modulation of vasomotor tone at the level of lateral medullary pressor area (LMPA).

Authors:  J N Sinha; S Gurtu; D K Sharma; K P Bhargava
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-09       Impact factor: 3.000

5.  Involvement of alpha2-adrenoceptors of nucleus tractus solitarius in baroreflex mediated bradycardia.

Authors:  S Gurtu; J N Sinha; K P Bhargava
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-10       Impact factor: 3.000

6.  Nucleus locus coeruleus: evidence for alpha 1-adrenoceptor mediated hypotension in the cat.

Authors:  J N Sinha; D K Sharma; S Gurtu; K K Pant; K P Bhargava
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-06       Impact factor: 3.000

7.  Involvement of central dopamine receptors in the hypotensive action of pergolide.

Authors:  A L Jadhav; R N Willett; H N Sapru; M F Lokhandwala
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-12       Impact factor: 3.000

8.  Alterations in blood pressure and REM sleep after pontine carbachol microinfusion.

Authors:  P J Shiromani; J M Siegel; K S Tomaszewski; D J McGinty
Journal:  Exp Neurol       Date:  1986-02       Impact factor: 5.620

9.  Cardiovascular and muscle tone changes produced by microinjection of cholinergic and glutamatergic agonists in dorsolateral pons and medial medulla.

Authors:  Y Y Lai; J M Siegel
Journal:  Brain Res       Date:  1990-04-23       Impact factor: 3.610

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.